Emily’s Entourage’s Translational Grants

The objective of this initiative is to fund promising therapies and drug-delivery mechanisms that have the potential to accelerate the development of gene-based therapies for people with CF.

Potential areas of interest include but are not limited to the following list.

• Nucleotide based therapies
• Viral and non-viral gene delivery technologies
• Treatment and prevention of Staphylococcus aureus and other clinically important pathogens that present an unmet need in people with CF
• Drug repurposing
• Promising early-stage research

Funding: $100, 000 per year

Duration: 2 years

Research Authority due date: 12.12.24